Pref-1/DLK1/FA1 Antibody (MM0514-9D8) [Janelia Fluor® 646]
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-11855JF646
Conjugate
Catalog #
Forumulation
Catalog #
Key Product Details
Species Reactivity
Human
Applications
CyTOF-ready, Flow Cytometry, Western Blot
Label
Janelia Fluor 646
Antibody Source
Monoclonal Mouse IgG2 Clone # MM0514-9D8
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Human recombinant Pref-1/DLK1/FA1
Clonality
Monoclonal
Host
Mouse
Isotype
IgG2
Applications for Pref-1/DLK1/FA1 Antibody (MM0514-9D8) [Janelia Fluor® 646]
Application
Recommended Usage
CyTOF-ready
Optimal dilutions of this antibody should be experimentally determined.
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein G purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: Pref-1/DLK1/FA1
Long Name
Preadipocyte Factor-1/Protein delta Homolog 1/Fetal Antigen 1
Alternate Names
DLK-1, DLK1, FA1, pG2, Pref1, ZOG
Gene Symbol
DLK1
Additional Pref-1/DLK1/FA1 Products
Product Documents for Pref-1/DLK1/FA1 Antibody (MM0514-9D8) [Janelia Fluor® 646]
Product Specific Notices for Pref-1/DLK1/FA1 Antibody (MM0514-9D8) [Janelia Fluor® 646]
Sold under license from the Howard Hughes Medical Institute, Janelia Research Campus.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...